 JERSEY CITY, N.J., Feb. 25, 2021 GLOBE NEWSWIRE -- SCYNEXIS, Inc. NASDAQ: SCYX, a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that Marco Taglietti, President and Chief Executive Officer, will participate in a panel discussion during Maxim Group LLCs Late Stage Innovations in Womens Health event, which is part of the M-Vest Virtual Conference series. The virtual event will take place at 11:00 am Eastern Time on March 4, 2021. 